The company's clinical chemistry test uses the NGAL biomarker to determine a patient's risk of acute kidney injury.

Proscia has integrated its Concentriq platform with AWS HealthImaging to provide a cloud-native foundation for pathology.

The submitted test runs on the firm's point-of-care instrument and detects four respiratory pathogens within 10 minutes directly from patient nasal swab samples.

The program is intended to advance the development of antigen tests that can be used in homes and at the point-of-care to aid the detection of dangerous infections.

Last week, readers were most interested in a story about a possible sale of Siemens Healthineer's IVD business, leading to an uptick in the company's share price.

Under the agreement, Tempus and Renalytix will work with US healthcare systems to make the KidneyintelX.dkd test more available to order within existing clinical workflows.

Titled the RESULTS Act, the bill would use third-party private-payor data to set Medicare lab payment rates, addressing a ...

The scientists said that the test could help clinicians overcome a lack of specificity in prostate-specific antigen tests and ...

Compared to the firm's previous PGx offering, the new service is somewhat smaller in terms of content and better supported by ...

Auditors said that independent diagnostic labs should be subject to emergency planning rules similar to those already required for various other healthcare providers.

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

With the new certification, the full portfolio of QiaStat-Dx qPCR-based multiplex panels and instruments is now CE-IVDR certified.